Uptake and distribution of catechins in fetal organs following in utero exposure in rats

Human Reproduction

Volumn 22, Issue 1, 2007, Pages 280-287

  Chu, K O ^a   Wang, C C ^a   Chu, C Y ^a   Choy, K W ^a   Pang, C P ^a   Rogers, M S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antioxidant; Catechins; Distribution; Fetal tissues; Green tea

Indexed keywords

CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN; GREEN TEA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG RETENTION; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG UPTAKE; EYE; FEMALE; FETUS; GESTATION PERIOD; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LUNG; NONHUMAN; PREGNANCY; PRENATAL DRUG EXPOSURE; RAT; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION;

EID: 33845600030     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/del353     Document Type: Article

References (49)

1. Ahmad N, Mukhtar H (1999) Green tea polyphenols and cancer: Biologic mechanisms and practical implications. Nutr Rev 57,78-83.
2. Benders MJ, Bos AF, Rademaker CM, Rijken M, Torrance HL, Groenendaal F, van Bel F (2006) Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia. Arch Dis Child Fetal Neonatal Educ 91,F163-165.
3. Bodor N, Prokai L, Wu WM, Somogyi G and Farag H (1995) Sequential bioactivation of methoxime analogs of beta-adrenergic antagonists in the eye. J Ocul Pharmacol Ther 11,305-318.
4. Bracci R, Perrone S and Buonocore G (2006) The timing of neonatal brain damage. Biol Neonate 90,145-155.
5. Cherubini A, Beal MF and Frei B (1999) Black tea increases the resistance of human plasma to lipid peroxidatoin in vitro, but not ex vivo. Free Radic Biol Med 27,381-387.
6. Chu KO, Wang CC, Chu CY, Rogers MS, Choy KW and Pang CP (2004) Method for determination of catechins and catechin gallates in tissues by HPLC with coulometric with coulometric array detection and selective solid phase extraction. J Chromatogr B 810,187-195.
7. Chu KO, Wang CC, Chu CY, Chan KP, Rogers MS, Choy KW and Pang CP (2006) Pharmacokinetic studies of green tea catechins in maternal plasma and fetus in rats. J Pharm Sci 95,1372-1381.
8. Cornish KM, Williamson G and Sanderson J (2002) Quercetin metabolism in the lens: Role in inhibition of hydrogen peroxide induced cataract. Free Radic Biol Med 33,63-70.
9. Eberhardt MK (2001) Reactive Oxygen Metabolites. Chemistry and Medical Consequences. CRC Press, New York.
10. Fiscella RG, Gieser J, Phillpotts B, Gilmartin C, Labib S, Cwik MJ, Solomon MJ and Shapiro MJ (1998) Intraocular penetration of gentamicin after once-daily aminoglycoside dosing. Retina 18,339-342.
11. Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, Barberi S, Cordaro S and Barberi I (2001) Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborn: Reduction by melatonin. J Pineal Res 31,343-349.
12. Gabrielesson JL and Weiner DL (2000) Non-compartmental analysis. In Pharmacokinetic and Pharmacodynamic Data Analysis Gabrielesson JL, Weiner DL and Swedish Pharmaceutical Society (eds). Swedish Pharmaceutical Press, pp. 141-174.
13. Geetha T, Garg A, Chopra K and Pal Kaur I (2004) Delineation of antimutagenic activity of catechin, epicatechin and green tea extract. Muatat Res 556,65-74.
14. Harada M, Kara Y and Naoki H (1999) Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci Biotechnol Biochem 63,973-977.
15. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Yun YP, Lee BM and Kim PY (2001) Protective effect of green tea extract on ischemia/ reperfusion-induced brain injury in Mongolian gerbils. Brain Res 888,11-18.
16. Inanami O, Watanabe Y, Syuto B, Nalano M, Tsuji M and Kuwabara M (1998) Oral administrartion of (-)-catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil. Free Radic Biol Med 29,359-365.
17. Isbrucker RA, Edwards JA, Wolz E, Davidovich A and Bausch J (2005) Safety studies on epigallocatechin gallate (EGCG) preparation. Part 3: teratogenicity and reproducibility toxicity studies in rats. Food Chem Toxicol 44,651-661.
18. Johnston MV, Trescher WH, Ishida A and Nakajima W (2001) The developing nervous system: A series of review articles. Pediatr Res 49,735-741.
19. Khalil AA, Aziz FA and Hall JC (2006) Reperfusion injury. Plast Reconstr Surg 117,1024-1033.
20. Khan N, Afaq F, Saleem M, Ahmad N and Mukhtar H (2006) Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66,2500-2505.
21. Kida K, Suzuki M, Matsumoto N, Nanjo F and Hara Y (2000) Identification of biliary metabolites of (-)-epigallocatechin gallate in rats. J Agric Food Chem 48,4151-4155.
22. Mak S and Neuton GE (2001) The oxidative stress hypothesis of congestive heart failure: Radical thoughts. Chest 120,2035-2046.
23. Meng XF, Sang SM, Zhu NQ, Lu H, Sheng SQ, Lee MJ, Ho CT and Yang CS (2002) Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in human, mice and rats. Chem Res Toxicol 15,1042-1050.
24. Mitscher LA, Jung M, Shankel D, Dou JH, Steele L and Pilllai SP (1997) Chemoprotection: A review of the potential therapeutic antioxidant properties of green tea (Camellia Sinensis) and certain of its constituents. Med Res Rev 17,327-365.
25. Mooney LA, Madsen AM, Tang D, Orjuela MA, Tsai WY, Garduno ER and Perera FP (2005) Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential common risk in female smokes. Cancer Epidemiol Biomarkers Prev 14,237-242.
26. Naggar H, Van Ells TK, Ganapathy V and Smith SB (2005) Regulation of reduced-folate transporter-1 in retinal pigment epithelial cells by folate. Curr Eye Res 30,35-44.
27. Nie G, Jin C, Cao Y, Shen S and Zhao B (2002) Distinct effects of tea catechins on 6-hydroxydopamine induced apoptosis in PC12 cells. Arch Biochemi Biophys 397,84-90.
28. Poston L, Briley AL, Seed PT, Kelly FJ and Shennan AH (2006) Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet 367,1145-1154.
29. Quintana-Hau JD, Cruz-Olmos E, Lopez-Sanchez MI, Sanchez-Castellanos V, Baiza-Duran L, Gonzalez JR, Tornero-Montano, Mondragon-Flores R and Hernandez-Santoyo A (2005) Characterization of the novel ophthalmic drug carrier Sophisen in two of its derivatives: 3A Ofteno and Modusik-A Ofteno. Drug Dev Ind Pharm 31,263-269.
30. Rice-Evans C (1995) Plant polyphenols: Free radical scavengers or chain-breaking antioxidants. Biochem Soc Symp 61,103-116.
31. Rice-Evans CA and Diplock AT (1993) Current status of antioxidant therapy. Free Radic Biol Med 15,77-96.
32. Rosenfeld WN and Davis JM (1998) Prevention of oxygen radical disease in the newborn: Possible therapeutic approaches. Semin Neonatol 3,239-244.
33. Sagar SM (2006) Should patients take or avoid antioxidant supplement during anticancer therapy? An evidence-base review. Current Oncol 12,44-54 (http://www.aminomics.com/antioxidants_cancer.pdf).
34. Saugstad OD (1998) Oxygen radical disease in neonatology. Semin Neonatol 3,229-238.
35. Soucy NV, Parkinson HD, Sochaski MA and Borghoff SJ (2006) Kinetics of genistein and its conjugated metabolites in pregnant Sprague-Dawley rats following single and repeated genistein administration. Toxicol Sci 90,230-240.
36. Stanwood GD and Levitt P (2004) Drug exposure early in life: Functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4,65-71.
37. Takizawa Y, Morota T, Takeda S and Aburada M (2003) Pharmacokinetics of (-)-epicatechin-3-o-gallate, an active component of Onpi-to, in rats. Pharm Bull 26,608-612.
38. Tastekin A, Ors R, Demircan B, Saricam Z, Ingec M and Akcay F (2005) Oxidative stress in infants born to preclamptic mother. Pediatr Int 47,658-662.
39. Thiagarajan G, Chandani S, Sundari CS, Rao SH, Kulkarni AV and Balasubramanian D (2001) Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exp Eye Res 73,393-401.
40. Tin W and Wariyar U (2002) Giving small babies oxygen: 50 years of uncertainty. Semin Neonatol 7,361-367.
41. Unadkat JD, Kahlin A and Vijay S (2004) Placental Drug Transporters. Curr Drug Metabol 5,125-131.
42. Varadharaj S, Steinhour E, Hunter MG, Watkins T, Baran CP, Magalang U, Kuppusamy P, Zweier JL, Marsh CB, Natarajan V and Parinandi NL (2006) Vitamin C-induced activation of phospholipase D in lung microvascular endothelial cells: Regulation by MAP kinases. Cell Signal 18,1396-1407.
43. Wang HK, Xia Y, Yang ZY, Natschke SLM and Lee KH (1998) Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. In Flavonoids in the Living System. Manthey JA and Bustig BS (eds.) Plenum Press, New York, pp. 191-225.
44. Xiang H, Pan S and Li S (1998) Studies on human embryonic lens crystallins under oxidative stress and protective effects of tea polyphenols. Yan Ke Xue Bao 14,170-175.
45. Yamakoshi J, Saito M, Kataoka S and Tokutake S (2002) Procyanidin-rich extract from grape seeds prevents cataract formation in hereditary cataractous (ICR/f) rats. J Agric Food Chem 50,4983-4988.
46. Yang CS and Landau JM (2000) Effects of tea consumption on nutrition and health. J Nutr 130,2409-2412.
47. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC and Schantz SP (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 7,351-354.
48. Zhong Z, Froh M, Connor HD, Li X, Conzelmann LO, Mason RP, Lemasters JJ and Thurman RG (2002) Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am J Physiol Gastrointest Liver Physiol 283,G957-G964.
49. Zhu BT, Patel UK, Cai MX and Conney AH (2000) O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-o-methyltransferase. Drug Metab Dispos 28,1024-1030.